SLE is an autoimmune disease in which the immune system attacks its own tissues, causing widespread inflammation and tissue damage in the affected organs. It can affect the joints, skin, brain, lungs, kidneys, and blood vessels. Plaquenil eye grid waves Doxycycline hyclate and plaquenil Chloroquine natural resources User Reviews for Hydroxychloroquine to treat Systemic Lupus Erythematosus. Also known as Plaquenil, Quineprox. The following information is NOT intended to endorse any particular medication. While these reviews might be helpful, they are not a substitute for the expertise, skill, knowledge and judgement of healthcare practitioners. Overview. Background. Hydroxychloroquine HCQ is an antimalarial drug that is recommended as a safe, daily prophylactic intervention for individuals with systemic lupus erythematosus SLE based on previous studies that showed an association of HCQ use with reductions in flares compared with placebo. Hydroxychloroquine is a one of a number of drugs which have been used for many years in the treatment of malaria. Fortunately, it was discovered these drugs often are helpful in the treatment of various rheumatic diseases, particularly systemic lupus erythematosus SLE or "Lupus" and rheumatoid arthritis. The seriousness of SLE can range from mild to life-threatening. There is no cure for lupus, but medical interventions and lifestyle changes can help control it. Hydroxychloroquine for systemic lupus erythematosus Hydroxychloroquine Serum Concentrations and Flares of Systemic Lupus., Outcomes of Systemic Lupus Erythematosus in Patients who Discontinue. Plaquenil lupus reviews Systemic lupus erythematosus in three ethnic groups XVI. Association of hydroxychloroquine use with reduced risk of damage accrual. Third, apart from its direct effects on SLE activity, hydroxychloroquine seems to protect against thrombotic events and has a beneficial effect on lipid profiles. Hydroxychloroquine in systemic lupus erythematosus - The.. Plaquenil. A medication for Lupus. Hydroxychloroquine MedlinePlus Drug Information. Systemic lupus erythematosus SLE, also known simply as lupus, is an autoimmune disease in which the body's immune system mistakenly attacks healthy tissue in many parts of the body. Symptoms vary between people and may be mild to severe. The use of hydroxychloroquine HCQ in patients with systemic lupus erythematosus SLE is associated with reductions in serum low-density lipoprotein cholesterol LDL-C levels. Results of a literature search conducted by an international team of researchers was published in the International Journal of Rheumatic Diseases. Long-term treatment with the antimalarial drug hydroxychloroquine is safe in patients with systemic lupus erythematosus. • A cumulative dose of hydroxychloroquine 600 g taken for 5 years or more independently and significantly reduced the risk of cardiovascular events in patients with systemic lupus erythematosus.